Skip to main content
OpenTrials

Clinical trial condition

Diabetic Macular Edema

Explore clinical trials studying Diabetic Macular Edema. Study availability and eligibility vary by location and protocol.

349 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Diabetic Macular Edema trial results

Active, Not Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)

NCT06847854

Conditions
Diabetic Macular Edema
Locations
  • Barnet Dulaney Perkins Eye Center Mesa, Arizona, United States
  • Retinal Consultants of AZ, Ltd Peoria, Arizona, United States
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Arkansas Retina Research Little Rock, Arkansas, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema

NCT05224102

Conditions
Diabetic Macular Edema
Locations
  • Barnet Dulaney Perkins Eye Center Phoenix, Arizona, United States
  • Win Retina Arcadia, California, United States
  • Retinal Diagnostic Center Campbell, California, United States
  • Retina Consultants of Orange County Fullerton, California, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)

NCT06439576

Conditions
Cardiovascular Diseases, Diabetic Macular Edema, Embolism and Thrombosis, +7 more
Locations
  • Joint Shantou International Eye Center Shantou, Guangdong, China
  • The First Affiliated Hospital of Henan UN of Science and Technology Luoyang, Henan, China
  • Taihe Hospital of Shiyan Shiyan, Hubei, China
  • Xuzhou No.1 Peoples Hospital Xuzhou, Jiangsu, China
View all 41 locations
View Trial Details
Active, Not Recruiting

Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant

NCT05978622

Conditions
Diabetic Macular Edema
Locations
  • Uza /Id# 255831 Edegem, Antwerpen, Belgium
  • CHU Saint Pierre /ID# 257650 Brussels, Brussels Capital, Belgium
  • Universitair Ziekenhuis Brussel /ID# 255324 Jette, Brussels Capital, Belgium
  • Ziekenhuis Oost-Limburg, Campus St.-Jan /ID# 255934 Genk, Limburg, Belgium
View all 54 locations
View Trial Details
Active, Not Recruiting

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

NCT05610319

Conditions
Diabetic Macular Edema
Locations
  • Retinal Consultants Medical Group Inc. Modesto, California, United States
  • Vitreo-Retina Medical Group Sacramento, California, United States
  • University Retina and Macula Associates Oak Forest, Illinois, United States
  • Eye Associates of Northeast Louisiana Dba Haik Humble Eye Center West Monroe, Louisiana, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Evaluation of Tonabersat for DME

NCT05727891

Conditions
Diabetic Macular Edema
Locations
  • Retina Associates of Southern California Huntington Beach, California, United States
  • Loma Linda University Loma Linda, California, United States
  • East Bay Retina Consultants, Inc. Oakland, California, United States
  • Southern California Desert Retina Consultants, Inc. Palm Desert, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX)

NCT04116398

Conditions
Diabetic Macular Edema
Locations
  • APHP - Hôpital Avicenne Bobigny, France
  • CHU Bordeaux - Hôpital Pellegrin Bordeaux, France
  • Centre Rétine Gallien Bordeaux, France
  • Hôpital Intercommunal de Créteil Créteil, France
View all 16 locations
View Trial Details
Active, Not Recruiting

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

NCT06491914

Conditions
Diabetic Macular Edema, Neovascular Age-related Macular Degeneration
Locations
  • Win Retina - Arcadia Arcadia, California, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retina Specialists of Beverly Hills Beverly Hills, California, United States
  • Salehi Retina Institute dba Retina Associates of Southern California Huntington Beach, California, United States
View all 54 locations
View Trial Details
Active, Not Recruiting

4D-150 in Patients With Diabetic Macular Edema

NCT05930561

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +7 more
Locations
  • Cumberland Valley Retina Consultants Hagerstown, Maryland, United States
  • Verum Research, LLC Eugene, Oregon, United States
  • Erie Retina Research Erie, Pennsylvania, United States
  • Austin Clinical Research Austin, Texas, United States
View Trial Details

Related conditions